Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Dianthus Therapeutics Inc (DNTH)
Dianthus Therapeutics Inc (DNTH) Actualités

DNTH

Dianthus Therapeutics (DNTH)

Dianthus Therapeutics Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:DNTH

1

Date	Heure	Source	Titre	Symbole	Société
07/11/2024	22h01	GlobeNewswire Inc.	Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results	NASDAQ:DNTH	Dianthus Therapeutics Inc
04/11/2024	13h00	GlobeNewswire Inc.	Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences	NASDAQ:DNTH	Dianthus Therapeutics Inc
15/10/2024	13h00	GlobeNewswire Inc.	Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting	NASDAQ:DNTH	Dianthus Therapeutics Inc
04/09/2024	13h00	GlobeNewswire Inc.	Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September	NASDAQ:DNTH	Dianthus Therapeutics Inc
08/08/2024	22h01	GlobeNewswire Inc.	Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results	NASDAQ:DNTH	Dianthus Therapeutics Inc
28/06/2024	17h30	GlobeNewswire Inc.	Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)	NASDAQ:DNTH	Dianthus Therapeutics Inc
12/06/2024	13h00	GlobeNewswire Inc.	Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)	NASDAQ:DNTH	Dianthus Therapeutics Inc
30/05/2024	22h30	GlobeNewswire Inc.	Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference	NASDAQ:DNTH	Dianthus Therapeutics Inc
09/05/2024	22h01	GlobeNewswire Inc.	Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results	NASDAQ:DNTH	Dianthus Therapeutics Inc
08/05/2024	22h30	GlobeNewswire Inc.	Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference	NASDAQ:DNTH	Dianthus Therapeutics Inc
03/05/2024	22h30	GlobeNewswire Inc.	Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:DNTH	Dianthus Therapeutics Inc
11/04/2024	13h30	GlobeNewswire Inc.	Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting	NASDAQ:DNTH	Dianthus Therapeutics Inc
21/03/2024	21h01	GlobeNewswire Inc.	Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results	NASDAQ:DNTH	Dianthus Therapeutics Inc
07/03/2024	22h30	GlobeNewswire Inc.	Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:DNTH	Dianthus Therapeutics Inc
26/02/2024	13h00	GlobeNewswire Inc.	Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)	NASDAQ:DNTH	Dianthus Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:DNTH

1

Exchange Traded Fund Amu...

Societe Generale Effekten

BNP Paribas Issuance

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales